Search results
GM Touts Racing Innovation, IP Boon as It Bids to Join Formula 1
Bloomberg Law· 4 hours agoa spotlight in Netflix’s blockbuster hit “Drive to Survive,” it would give the carmaker an invaluable pipeline of innovation. Participation in F1 helps car manufacturers design racing features ...
Sensing Success: OpenAI, Anthropic And 40+ Others Leverage Multimodal AI
Forbes· 8 hours agoThe AI industry terms this ‘multimodal learning’. UNITED STATES - SEPTEMBER 13: Clément Delangue,...
1 Unstoppable Stock That Could Join Microsoft, Apple, Nvidia, Alphabet, Amazon, and Meta Platforms...
Motley Fool via Yahoo Finance· 3 days agoFurthermore, Broadcom has struggled with headwinds born of the cyclicality inherent in some of its...
3 Simple Tools To Be More Inclusive When Leading Remote/Hybrid Teams
Forbes· 8 hours agoInclusion needs to be a business imperative, because it’s imperative for any business that wants to...
Carlo Acutis: what the first ‘millennial saint’ says about the Catholic church’s future
The Conversation· 8 hours agoThe London-born Italian teenager Carlo Acutis is likely to become the first “millennial saint” after two miracles attributed to him were recognised by Pope Francis. Spending most of his life ...
Review: Checking out the TCL 50 8GB smartphone
Digital Journal· 4 days agoA relative new smartphone to appear on the market and one packed with features but at a budget price is the TCL 50 5G. TCL Communication Technology...
A 100-Ton Locomotive With No One in the Cab
The New York Times via Yahoo News· 1 day agoBUFFALO, N.Y. — One evening last June, as Esther Iradukunda set the table for dinner at her home in Buffalo, she heard a high-pitched cry through the...
How Leaders Can Navigate AI Challenges And Cultivate Public Trust
Forbes· 8 hours agoOne of the public's primary concerns is AI's effect on employment. This apprehension is particularly...
Ransomware Group Claims Responsibility for Christie’s Hack
New York Times· 15 hours agoIn a post on the dark web on Monday, the group claimed that it had gained access to sensitive...
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development...
Morningstar· 2 hours agoTÜBINGEN, GERMANY AND BOSTON, MA / ACCESSWIRE / May 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based ...